V
Valérie Dubois
Researcher at National Blood Service
Publications - 135
Citations - 3617
Valérie Dubois is an academic researcher from National Blood Service. The author has contributed to research in topics: Transplantation & Human leukocyte antigen. The author has an hindex of 27, co-authored 122 publications receiving 2875 citations. Previous affiliations of Valérie Dubois include University of Lyon & University of the West Indies.
Papers
More filters
Journal ArticleDOI
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study
Katharina Fleischhauer,Bronwen E. Shaw,Bronwen E. Shaw,Ted Gooley,Mari Malkki,Peter G Bardy,Peter G Bardy,Jean Denis Bignon,Valérie Dubois,Mary M. Horowitz,J. Alejandro Madrigal,Yasuo Morishima,Machteld Oudshoorn,Olle Ringdén,Stephen R. Spellman,Andrea Velardi,Elisabetta Zino,Effie W. Petersdorf +17 more
TL;DR: A retrospective study compared outcomes between permissive and non-permissive HLA-DPB1 mismatches in unrelated-donor haemopoietic-cell transplantation to identify mismatches that might be tolerated and those that would increase risks after transplantation.
Journal ArticleDOI
Detection of C3d-Binding Donor-Specific Anti-HLA Antibodies at Diagnosis of Humoral Rejection Predicts Renal Graft Loss
Antoine Sicard,Antoine Sicard,Stéphanie Ducreux,Maud Rabeyrin,Lionel Couzi,Brigitte McGregor,Lionel Badet,Jean-Yves Scoazec,Thomas Bachelet,Sébastien Lepreux,Jonathan Visentin,Pierre Merville,Véronique Frémeaux-Bacchi,Emmanuel Morelon,Emmanuel Morelon,Jean-Luc Taupin,Valérie Dubois,Olivier Thaunat,Olivier Thaunat +18 more
TL;DR: It is concluded that assessment of the C3d-binding capacity of DSA at the time of AMR diagnosis allows for identification of patients at risk for allograft loss.
Journal Article
Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?
Olga Serova,Sylvie Mazoyer,Nadine Puget,Valérie Dubois,Patricia N. Tonin,Yin Y. Shugart,David E. Goldgar,Steven A. Narod,Henry T. Lynch,Gilbert M. Lenoir +9 more
TL;DR: The results suggest the existence of at least one more major breast cancer-susceptibility gene, and it would expect 8-10 site-specific female breast cancer families of the series to be due to neither BRCA1 nor BRCa2.
Journal ArticleDOI
DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe.
Mehdi Tafti,Mehdi Tafti,Hyun Hor,Hyun Hor,Yves Dauvilliers,Gert J. Lammers,Sebastiaan Overeem,Geert Mayer,Sirous Javidi,Alex Iranzo,Joan Santamaria,Rosa Peraita-Adrados,José L. Vicario,Isabelle Arnulf,Giuseppe Plazzi,Sophie Bayard,Francesca Poli,Fabio Pizza,Peter Geisler,Aleksandra Wierzbicka,Claudio L. Bassetti,Johannes Mathis,Michel Lecendreux,Claire E H M Donjacour,Astrid van der Heide,Raphael Heinzer,José Haba-Rubio,Eva Feketeova,Birgit Högl,Birgit Frauscher,Antonio Benetó,Ramin Khatami,Francesca Canellas,Corinne Pfister,Sabine Scholz,Michel Billiard,Christian R. Baumann,Guadalupe Ercilla,Willem Verduijn,Frans H.J. Claas,Valérie Dubois,Jacek Nowak,Hans Peter Eberhard,Sylvain Pradervand,Sylvain Pradervand,Charlotte N. Hor,Manuela Testi,Jean-Marie Tiercy,Zoltán Kutalik,Zoltán Kutalik,Zoltán Kutalik +50 more
TL;DR: An overwhelming portion of genetic risk for narcolepsy with cataplexy is found at DQB1 locus and may be relevant to public health policy.
Journal ArticleDOI
HLA Association with Hematopoietic Stem Cell Transplantation Outcome: The Number of Mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 Is Strongly Associated with Overall Survival
Pascale Loiseau,Marc Busson,Marie-Lorraine Balere,A. Dormoy,Jean-Denis Bignon,Katia Gagne,L. Gebuhrer,Valérie Dubois,Isabelle Jollet,Monique Bois,Pascale Perrier,Dominique Masson,Agnès Moine,L. Absi,Denis Reviron,Virginia Lepage,Ryad Tamouza,Antoine Toubert,Evelyne Marry,Zina Chir,Jean-Pierre Jouet,Didier Blaise,Dominique Charron,Colette Raffoux +23 more
TL;DR: negative effects of HLA mismatching for either HLA-A, -B, -C, -DRB1, or -DQB1 loci on survival are demonstrated, and "Missing killer cell immunoglobulin-like receptor (KIR) ligand" evaluated on the presence of Hla-C2, and Bw4 groups in the recipients was not associated with aGVHD, survival, and relapse in this cohort of non-T cell-depleted HS